Mike Moyer
Host, LifeSci Advisors
Replay available
Protalix BioTherapeutics, Inc. (DE) (PLX) Q2 2025 Earnings Call
Protalix BioTherapeutics, Inc. (DE) (AMEX: PLX) Q2 2025 earnings conference call, held 2025-08-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dror Bashan
President & Chief Executive Officer, ProTalix Biotherapeutics
I.L. Rubens
Senior Vice President & Chief Financial Officer, ProTalix Biotherapeutics
John Vandermosten
Analyst, Zack’s SCR
Dar Barshis
Private Investor
Gilad Mablo
Incoming Chief Financial Officer, ProTalix Biotherapeutics
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Protalix Biotherapeutics, Inc. (de).
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.158 Good morning, ladies and gentlemen, and welcome to the ProTalix Biotherapeutics 00:00:05.158 -- 00:00:10.324 Second Quarter 2025 Financial and Business Results Conference Call. 00:00:10.324 -- 00:00:13.328 As a reminder, this conference is being recorded. 00:00:13.328 -- 00:00:15.992 I will now turn the conference over to our host, Mr. 00:00:15.992 -- 00:00:21.076 Mike Moyer with LifeSci Advisors. You may begin your conference. 00:00:21.739 -- 00:00:26.345 Thank you, Operator, and welcome to the ProTalix Biotherapeutics Second Quarter 2025 00:00:26.345 -- 00:00:29.866 Financial Results and Business Update Conference Call. 00:00:29.866 -- 00:00:34.191 With me today are Dror Bashan, President and CEO of Portalix, I.L. 00:00:34.191 -- 00:00:37.796 Rubens, Senior Vice President and Chief Financial Officer. 00:00:37.796 -- 00:00:41.881 A press release announcing the financial results for the quarter in corporate updates 00:00:41.881 -- 00:00:45.666 was issued this morning and is now available on the Portalix website. 00:00:45.666 -- 00:00:49.190 Please take a moment to read the disclaimer about forward-looking statements in the press 00:00:49.190 -- 00:00:53.660 release. The earnings released in this teleconference include forward-looking statements. 00:00:53.660 -- 00:00:56.825 These forward-looking statements are subject to known and unknown risks and uncertainties 00:00:56.825 -- 00:01:00.570 that may cause actual results to differ materially from the statements made. 00:01:00.570 -- 00:01:04.897 Factors that could cause actual results to differ are described in the disclaimer and 00:01:04.897 -- 00:01:08.422 in Bratalex's filings with the U.S. Securities and Exchange Commission. 00:01:08.422 -- 00:01:10.646 I will now turn the call ...